Scholar Rock Holding (SRRK) Return on Capital Employed Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | -3,280.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,280.00 |
| Dec 31, 2025 | -1,911.00 |
| Sep 30, 2025 | 2,566.00 |
| Jun 30, 2025 | -208.00 |
| Mar 31, 2025 | 812.00 |
| Dec 31, 2024 | -2,095.00 |
| Sep 30, 2024 | -7,311.00 |
| Jun 30, 2024 | -3,844.00 |
| Mar 31, 2024 | -2,105.00 |
| Dec 31, 2023 | -2,926.00 |
| Sep 30, 2023 | -3,328.00 |
| Jun 30, 2023 | -1,929.00 |
| Mar 31, 2023 | -1,060.00 |
| Dec 31, 2022 | 1,502.00 |
| Sep 30, 2022 | 1,352.00 |
| Jun 30, 2022 | -180.00 |
| Mar 31, 2022 | -1,188.00 |
| Dec 31, 2021 | -1,755.00 |
| Sep 30, 2021 | 942.00 |
| Jun 30, 2021 | 1,152.00 |
| Mar 31, 2021 | 643.00 |
| Dec 31, 2020 | -307.00 |
| Sep 30, 2020 | -2,152.00 |
| Jun 30, 2020 | -1,575.00 |
| Mar 31, 2020 | -52.00 |
| Dec 31, 2019 | 1,028.00 |
| Sep 30, 2019 | 422.00 |